P3 Health Partners Inc. (PIII)
NASDAQ (CM) NASDAQ (CM) Primary 
P3 Health Partners Inc. (PIII) Q3 2025 Earnings Call Transcript
P3 Health Partners Inc. ( PIII ) Q3 2025 Earnings Call November 14, 2025 8:00 AM EST Company Participants Aric Coffman - CEO, President & Director Amir Bacchus - Co-Founder, Chief Medical Officer & Director Leif Pedersen - Chief Financial Officer Conference Call Participants Gabriella Gabel Joshua Raskin - Nephron Research LLC Ryan Langston - TD Cowen, Research Division David Larsen - BTIG, LLC, Research Division Presentation Operator Good day, and welcome to the P3 Health's Third Quarter 2025 Earnings Call. [Operator Instructions] Please note, this event is being recorded.
P3 Health Partners Inc. (PIII) Q2 2025 Earnings Call Transcript
P3 Health Partners Inc. (NASDAQ:PIII ) Q2 2025 Earnings Conference Call August 14, 2025 4:30 PM ET Company Participants Amir Bacchus - Co-Founder, Chief Medical Officer & Director Aric Coffman - CEO, President & Director Leif Pedersen - Chief Financial Officer Conference Call Participants Aaron Wukmir - Lake Street Capital Markets, LLC, Research Division David Michael Larsen - BTIG, LLC, Research Division Joshua Richard Raskin - Nephron Research LLC Ryan M. Langston - TD Cowen, Research Division Ryan K.
Bears are Losing Control Over P3 Health Partners (PIII), Here's Why It's a 'Buy' Now
After losing some value lately, a hammer chart pattern has been formed for P3 Health Partners (PIII), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
Down 18.4% in 4 Weeks, Here's Why You Should You Buy the Dip in P3 Health Partners (PIII)
The heavy selling pressure might have exhausted for P3 Health Partners (PIII) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
P3 Health Partners Inc. (PIII) Q1 2025 Earnings Call Transcript
P3 Health Partners Inc. (NASDAQ:PIII ) Q1 2025 Earnings Conference Call May 15, 2025 4:30 PM ET Company Participants Ryan Halstead - Managing Director, Gilmartin Group LLC, IR Aric Coffman - CEO Leif Pedersen - CFO Amir Bacchus - Chief Medical Officer Conference Call Participants Josh Raskin - Nephron Research Ryan Langston - TD Cowen Operator Good day, and welcome to the P3 Health Partners First Quarter 2025 Earnings Conference Call. All participants will be in listen-only-mode.
P3 Health Partners Inc. (PIII) Reports Q1 Loss, Tops Revenue Estimates
P3 Health Partners Inc. (PIII) came out with a quarterly loss of $6.28 per share versus the Zacks Consensus Estimate of a loss of $5. This compares to loss of $8 per share a year ago.
P3 Health Partners (PIII) Stock Jumps 8.9%: Will It Continue to Soar?
P3 Health Partners (PIII) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
P3 Health Partners Inc. (PIII) Q4 2024 Earnings Conference Call Transcript
P3 Health Partners Inc. (NASDAQ:PIII ) Q4 2024 Earnings Conference Call March 27, 2025 4:30 PM ET Company Participants Ryan Halsted - IR Aric Coffman - CEO Leif Pedersen - CFO Amir Bacchus - Chief Medical Officer Conference Call Participants Josh Raskin - Nephron Research David Larsen - BTIG Ryan Langston - TD Cowen Jack Senft - William Blair Operator Good day and welcome to the P3 Health Partners' Fourth Quarter 2024 Earnings Conference Call. All participants will be in a listen-only mode.
P3 Health Partners Inc. (PIII) Reports Q4 Loss, Lags Revenue Estimates
P3 Health Partners Inc. (PIII) came out with a quarterly loss of $0.32 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to loss of $0.22 per share a year ago.
P3 Health Partners (PIII) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
P3 Health Partners (PIII) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
P3 Health Partners Inc. (PIII) Q3 2024 Earnings Call Transcript
P3 Health Partners Inc. (NASDAQ:PIII ) Q3 2024 Results Conference Call November 12, 2024 4:30 PM ET Company Participants Ryan Halsted - Investor Relations Aric Coffman - Chief Executive Officer Leif Pedersen - Chief Financial Officer Amir Bacchus - Chief Medical Officer Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Josh Raskin - Nephron Research Jenny Shen - BTIG Jack Senft - William Blair Operator Good day, and welcome to P3 Health Partners Third Quarter 2024 Earnings Call. [Operator Instructions] Please note, this event is being recorded.
P3 Health Partners Inc. (PIII) Reports Q3 Loss, Misses Revenue Estimates
P3 Health Partners Inc. (PIII) came out with a quarterly loss of $0.31 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to loss of $0.12 per share a year ago.
